Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Leroy Hood; James Karis; Jay Tenenbaum; Ruben Mesa

Premium

The Personalized Medicine Coalition has awarded Leroy Hood, president and co-founder of the Institute for Systems Biology, its 2011 Leadership in Personalized Medicine Award. The PMC recognized Hood for his "pioneering vision to transform medicine from reactive to predictive, preventive, personalized and participatory (P4 medicine)."

Hood and his colleagues helped developed the DNA and sequencers that were instrumental in mapping the human genome. He has also helped found 14 biotechnology companies and has published more than 700 peer-reviewed articles.


CollabRx has appointed James Karis as its new CEO. Jay Tenenbaum, company founder and former CEO, will remain as chairman of the board.

Karis most recently served as president and CEO of biosimulation firm Entelos. Prior to that, he was president and chief operating officer of Parexel International and COO of Pharmaco International. He has also held management positions at Baxter International and KMR Group.

Karis holds an MA in economics from American University and a BS in industrial management and economics from Purdue University.


23andMe has appointed Ruben Mesa as scientific advisor of its myeloproliferative neoplasms research project advisory board.

Mesa is a professor of medicine and chair of the division of hematology and medical oncology at the Mayo Clinic.

He holds a BS in nuclear engineering and physiology from the University of Illinois at Urbana-Champaign and an MD from the Mayo Clinic.


The Scan

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.

Estonian Biobank Team Digs into Results Return Strategies, Experiences

Researchers in the European Journal of Human Genetics outline a procedure developed for individual return of results for the population biobank, along with participant experiences conveyed in survey data.

Rare Recessive Disease Insights Found in Individual Genomes

Researchers predict in Genome Medicine cross-population deletions and autosomal recessive disease impacts by analyzing recurrent nonallelic homologous recombination-related deletions.

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.